Any 0 3 0 3 O
other 4 9 4 9 O
clinically 10 20 10 20 O
significant 21 32 21 32 O
medical 33 40 33 40 O
disease 41 48 41 48 O
or 49 51 49 51 O
condition 52 61 52 61 O
laboratory 62 72 62 72 O
abnormality 73 84 73 84 O
or 85 87 85 87 O
psychiatric 88 99 88 99 B-cancer
illness 100 107 100 107 I-cancer
that 108 112 108 112 O
, 112 113 112 113 O
in 114 116 114 116 O
the 117 120 117 120 O
investigator?s 121 135 121 135 O
opinion 136 143 136 143 O
, 143 144 143 144 O
may 145 148 145 148 O
interfere 149 158 149 158 O
with 159 163 159 163 O
protocol 164 172 164 172 O
adherence 173 182 173 182 O
or 183 185 183 185 O
a 186 187 186 187 O
subject?s 188 197 188 197 O
ability 198 205 198 205 O
to 206 208 206 208 O
give 209 213 209 213 O
informed 214 222 214 222 O
consent 223 230 223 230 O

Hypercalcemia 0 13 231 244 B-chronic_disease

Patients 0 8 245 253 O
must 9 13 254 258 O
be 14 16 259 261 O
aware 17 22 262 267 O
of 23 25 268 270 O
the 26 29 271 274 O
neoplastic 30 40 275 285 O
nature 41 47 286 292 O
of 48 50 293 295 O
his 51 54 296 299 O
/ 54 55 299 300 O
her 55 58 300 303 O
disease 59 66 304 311 O
and 67 70 312 315 O
willingly 71 80 316 325 O
provide 81 88 326 333 O
written 89 96 334 341 O
, 96 97 341 342 O
informed 98 106 343 351 O
consent 107 114 352 359 O
after 115 120 360 365 O
being 121 126 366 371 O
informed 127 135 372 380 O
of 136 138 381 383 O
the 139 142 384 387 O
procedure 143 152 388 397 O
to 153 155 398 400 O
be 156 158 401 403 O
followed 159 167 404 412 O
, 167 168 412 413 O
the 169 172 414 417 O
nature 173 179 418 424 O
of 180 182 425 427 O
the 183 186 428 431 O
therapy 187 194 432 439 B-treatment
, 194 195 439 440 O
alternatives 196 208 441 453 O
, 208 209 453 454 O
potential 210 219 455 464 O
benefits 220 228 465 473 O
, 228 229 473 474 O
side 230 234 475 479 O
- 234 235 479 480 O
effects 235 242 480 487 O
, 242 243 487 488 O
risks 244 249 489 494 O
, 249 250 494 495 O
and 251 254 496 499 O
discomforts 255 266 500 511 O

Patients 0 8 512 520 O
must 9 13 521 525 O
have 14 18 526 530 O
histologically 19 33 531 545 O
confirmed 34 43 546 555 O
newly 44 49 556 561 O
diagnosed 50 59 562 571 O
or 60 62 572 574 O
previously 63 73 575 585 O
untreated 74 83 586 595 O
( 84 85 596 597 O
patients 85 93 597 605 O
may 94 97 606 609 O
be 98 100 610 612 O
under 101 106 613 618 O
no 107 109 619 621 O
treatment 110 119 622 631 B-treatment

Simultaneous 0 12 632 644 O
participation 13 26 645 658 O
in 27 29 659 661 O
other 30 35 662 667 B-treatment
therapeutic 36 47 668 679 I-treatment
clinical 48 56 680 688 I-treatment
trials 57 63 689 695 I-treatment
will 64 68 696 700 O
be 69 71 701 703 O
allowed 72 79 704 711 O

have 0 4 712 716 O
received 5 13 717 725 O
two 14 17 726 729 O
cycles 18 24 730 736 O
of 25 27 737 739 O
chemotherapy 28 40 740 752 B-treatment
or 41 43 753 755 O
localized 44 53 756 765 B-treatment
radiation 54 63 766 775 I-treatment
therapy 64 71 776 783 I-treatment
before 72 78 784 790 O
going 79 84 791 796 O
on 85 87 797 799 O
this 88 92 800 804 O
study 93 98 805 810 O
) 98 99 810 811 O
non 100 103 812 815 B-cancer
- 103 104 815 816 I-cancer
Hodgkin?s 104 113 816 825 I-cancer
lymphoma 114 122 826 834 I-cancer
or 123 125 835 837 O
CLL 126 129 838 841 B-cancer

